Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
KRYS on Nasdaq
DANIEL JANNEY - trading volume in the past year for Krystal Biotech, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
73,293 |
$20,241,071 |
$276.17 |
27 Feb 2026 |
Directly beneficially owned by Alta Bioequities, L.P. |
|
|
| Stock Option (Right to Buy) |
0 |
|
|
24 Feb 2026 |
Direct |
Common Stock |
|
Transactions reported by DANIEL JANNEY for Krystal Biotech, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.